Teva Pharmaceutical Industries Limited (TEVA)
Chart Events
Performance Outlook
| Previous Close | 7.55 |
| Open | 7.57 |
| Bid | 7.59 x 2200 |
| Ask | 7.60 x 4000 |
| Day's Range | 7.48 - 7.64 |
| 52 Week Range | 7.23 - 10.50 |
| Volume | |
| Avg. Volume | 9,849,803 |
| Market Cap | 8.405B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | 11.55 |
| EPS (TTM) | 0.66 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Nov 27, 2017 |
| 1y Target Est | 11.36 |
- Business Wire
Teva Announces Appointment of New Global R&D and Chief Medical Officer
TEL AVIV, Israel, July 01, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer. Dr. Hughes will begin his employment on August 1, 2022, and will be based out of Teva's U.S. headquarters in Parsippany, NJ.
- Business Wire
Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022
TEL AVIV, Israel, June 29, 2022--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2022 financial results on Wednesday, July 27, 2022 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.
- Motley Fool
2 Buffett Stocks That Outperformed the S&P During the Great Recession
There are two things that Teva Pharmaceutical Industries (NYSE: TEVA) and Amazon (NASDAQ: AMZN) have in common. While the index fell by 38% during that time, the healthcare company climbed 10% in value, and the tech giant's 8% decline was modest by comparison. Teva provides patients with generic medications that are much cheaper than brand-name drugs.
